Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive analysis of prime editing outcomes in human embryonic stem cells
Omer Habib, Gizem Habib, Gue‐Ho Hwang, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. 2, pp. 1187-1197
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Prime editing for precise and highly versatile genome manipulation
Peter J. Chen, David R. Liu
Nature Reviews Genetics (2022) Vol. 24, Iss. 3, pp. 161-177
Closed Access | Times Cited: 324
CRISPR-based genome editing through the lens of DNA repair
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 156
In vivo somatic cell base editing and prime editing
Gregory A. Newby, David R. Liu
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3107-3124
Open Access | Times Cited: 133
Efficient prime editing in mouse brain, liver and heart with dual AAVs
Jessie R. Davis, Samagya Banskota, Jonathan M. Levy, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 2, pp. 253-264
Open Access | Times Cited: 113
Prime editing: advances and therapeutic applications
Zhihan Zhao, Peng Shang, Prarthana Mohanraju, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 8, pp. 1000-1012
Open Access | Times Cited: 92
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Meirui An, Aditya Raguram, Samuel W. Du, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 10, pp. 1526-1537
Open Access | Times Cited: 92
Designing and executing prime editing experiments in mammalian cells
Jordan L. Doman, Alexander A. Sousa, Peyton B. Randolph, et al.
Nature Protocols (2022) Vol. 17, Iss. 11, pp. 2431-2468
Open Access | Times Cited: 81
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice
Kelcee A. Everette, Gregory A. Newby, Rachel M. Levine, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 5, pp. 616-628
Open Access | Times Cited: 73
In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model
Chang Li, Aphrodite Georgakopoulou, Gregory A. Newby, et al.
Blood (2023)
Open Access | Times Cited: 51
Prime editing with genuine Cas9 nickases minimizes unwanted indels
Jaesuk Lee, Kayeong Lim, Annie Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells
Alexander A. Sousa, Colin Hemez, Lei Lei, et al.
Nature Biomedical Engineering (2024)
Open Access | Times Cited: 23
Highly efficient generation of isogenic pluripotent stem cell models using prime editing
Hanqin Li, Oriol Busquets, Yogendra Verma, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 43
Efficient high-precision homology-directed repair-dependent genome editing by HDRobust
Stephan Riesenberg, Philipp Kanis, Dominik Macak, et al.
Nature Methods (2023) Vol. 20, Iss. 9, pp. 1388-1399
Open Access | Times Cited: 40
Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa
Sung-Ah Hong, Song‐Ee Kim, Ayeong Lee, et al.
Molecular Therapy (2022) Vol. 30, Iss. 8, pp. 2664-2679
Open Access | Times Cited: 39
Prime Editing for Human Gene Therapy: Where Are We Now?
Kelly Godbout, Jacques P. Tremblay
Cells (2023) Vol. 12, Iss. 4, pp. 536-536
Open Access | Times Cited: 26
Recent advances in prime editing technologies and their promises for therapeutic applications
Hongzhi Zeng, T. Daniel, Ananya Lingineni, et al.
Current Opinion in Biotechnology (2024) Vol. 86, pp. 103071-103071
Closed Access | Times Cited: 10
Delivery of Prime editing in human stem cells using pseudoviral NanoScribes particles
Thibaut Halegua, Valérie Risson, Julien Carras, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Prime Editing: Mechanistic Insights and DNA Repair Modulation
Astrid Mentani, Marcello Maresca, Anna Shiriaeva
Cells (2025) Vol. 14, Iss. 4, pp. 277-277
Open Access | Times Cited: 1
Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing
Dong Hyun Jo, Hyeon‐Ki Jang, Chang Sik Cho, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 31, pp. 16-27
Open Access | Times Cited: 38
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Paula Germino-Watnick, Malikiya Hinds, Anh‐Tuan Le, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1843-1843
Open Access | Times Cited: 35
Sickle Cell Disease: From Genetics to Curative Approaches
Giulia Hardouin, Elisa Magrin, Alice Corsia, et al.
Annual Review of Genomics and Human Genetics (2023) Vol. 24, Iss. 1, pp. 255-275
Open Access | Times Cited: 18
Advances in CRISPR/Cas gene therapy for inborn errors of immunity
Xinyi Liu, Guanglei Li, Yin Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing
Lori L. Bonnycastle, Amy J. Swift, Erin C. Mansell, et al.
The CRISPR Journal (2024) Vol. 7, Iss. 1, pp. 53-67
Open Access | Times Cited: 6
From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine
Weihui Xu, Shiyao Zhang, Huan Qin, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA
Shisheng Huang, Zhenwu Zhang, Wanyu Tao, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 2923-2932
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top